ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, EMILIN1, HOXA5, CCR2, HSPG2, DCN, HGS, CX3CR1, THBS1, TGFB2, PLK2, TIE1, CXCL10, TEK, PF4]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, CCL19, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, CD9, PRKCQ]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[TNF]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, NFKB1, MYD88, CD36, CHUK, IRAK3, TRAF1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, CD40LG]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, TLR4, MYD88, IL17A]
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;294.1477435792768;8.390779266560578;0.009844860261815976;0.7800242071602487;[LYN]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, INPP5D, NCKAP1L, HOXA5, LYN, INHBA, MAPK14]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, BMP2, CD40LG, CSPG4, PKN1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, TNF, SOX4, GHSR, IFNG, IL1B, CFTR, BLK, KCNA5, DPP4, CNR1, CCL5]
GO:0000185;activation of MAPKKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;6.8867018697843045;0.12404468480698592;0.814741218652794;[MAP4K1, TNF]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, RBBP8, E2F7, PRRX1, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX4, RUNX2, SFRP2, TWIST1, PCBP3, EGR1, BCL11A, ID1, IFNA2, PTPRK, XPO1, CD36, CBFA2T3, MDFIC, IL1B, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, BMP2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, PLCG1, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0045651;positive regulation of macrophage differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;7.212124270218933;0.0281402778535103;0.7650689957573628;[LIF, PF4]
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;7.474488534686424;0.00995955788091634;0.7331650565203278;[HHEX, HGS, EMILIN1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, AKT1, RAN]
GO:0097527;necroptotic signaling pathway;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;7.9853141584524145;7.75488093814194E-4;0.6986103492792611;[FASLG, TNF]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, GATA3, XCL1, TLR4, HAVCR2]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, COL1A1, NUP35, RAN]
GO:0072108;positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;8.0;1.0;0.875;9.628524252492122;682.945505833763;8.390779266560578;0.022857571469204727;0.8041048419030481;[LIF, PAX2]
GO:0007260;tyrosine phosphorylation of STAT protein;10.0;1.0;0.9152410118609203;9.628524252492122;339.94073760219794;7.57984905034425;0.011377510560744174;0.8028748447945538;[LIF]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, SFN, BARD1, LYN, PLK2, CDKN1A, CHAF1B, CHAF1A, CTLA4, SIRT1, UNG, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, COPS5, BCL6, CNOT3, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, PPP1R15A, RBBP8, POLR2E, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, SOX4, ESCO2, MIF, EPHA2, POLA1, BRCA2, RAD51C, SGK1, YAP1, PCNA, RAD54B, RPA1, MLH1, RPA3, DCLRE1A, PSMD14, HMGA1, JMY, TOPBP1, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[SPI1, CCL7]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, TEK]
GO:0002922;positive regulation of humoral immune response;6.0;0.6997970393407541;0.6730188322605215;9.0306872517365;108.8065326900253;7.069023426578259;0.0036416567296131998;0.6846304993685643;[FCER2, LTA, CCR7, FCGR2B, TNF]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[TGFB1, DLL1, TNF, CXCL10]
GO:0043242;negative regulation of protein complex disassembly;6.0;0.7248374789738407;0.6855390520770648;8.83001655627435;65.72942481560547;5.572381008289503;0.002199904695936496;0.6080921364962873;[LMOD1, TNF, EPS8, SPTA1, SPTAN1, GSN, CKAP2, IRAK3]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB1, AP2M1, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0002925;positive regulation of humoral immune response mediated by circulating immunoglobulin;10.0;0.8933024483968273;0.861892236059334;9.592156608321247;508.6670988930833;8.390779266560578;0.01702463002928348;0.8443458537639685;[FCER2, LTA, TNF]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, AKT1, CBFA2T3, PLK2, CAV1]
GO:0071803;positive regulation of podosome assembly;8.0;1.0;0.875;9.628524252492122;306.3544197830862;7.379178354882098;0.01025340672906212;0.7523715242355574;[TNF]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GAB1, VAV1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[BRCA2, HHEX, SLITRK6, HOXA5, RMI1, GRHL2, NDUFS6]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[PTGS2, TNF, KLRK1, AKT1, CD36, AGXT2, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[GOLT1B, TNF, AKT1, TNFSF11, F2R, CARD11, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, FLNA, FYN, CCL19, CCL21, CARD9, CD4, LTBR]
GO:1904999;positive regulation of leukocyte adhesion to arterial endothelial cell;8.0;1.0;0.875;9.628524252492122;88.73789627057504;9.777073627680469;0.0029699775292543833;0.875;[TNF]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, MSH6, MELK, MSH2, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, SFN, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, CD28, CD24, CDKN1A, FASLG, BRCA2, CD3E, DCC, PAWR, TNFRSF1B, SIRT1, IFNG, IL1B, TLR4, PPP1R15A, BCL2A1, SORT1, G0S2, MLH1]
GO:0043243;positive regulation of protein complex disassembly;6.0;0.7192862368539868;0.682763431017138;8.781226392104918;65.71852696664936;6.250713103064308;0.002199539954739362;0.6427820713687392;[ADRB2, TNF]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, AXIN2, TNFSF13, MAPK14, MYD88]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[ICAM2, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, NFKB1, CLEC4D, CARD11]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[TWIST1, TMEM64, AXIN2, TNF, ID1, HOXA2, MEN1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, PROS1, ITGB3, ITGA2B, F13A1, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, PCDH7, LHFPL2, PPBP, CD9, PF4]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[TGFB1, TSC2, TNF, PAX2, TMEM100, CCL5, IL1B, AKT1, CCL2, EPHA2]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, LYN, EIF2S1, CXCL10]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, IFNG, TNFSF11, IL17A]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[PAWR, DACH1, LTA]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[TGFB1, SPI1, CAMK4, LTBR]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, GATA3, FLRT2, HLA-DQA2, HLA-DQA1, HLA-DRB4, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, FOS, SIRT1, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IFNA14, IFNA16, IFNA10, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, FASLG, TNFSF13B, CHUK, TNFRSF1B, XCL1, CX3CR1, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, IRAK3, MMP9, DCN, IFNG, LTA, SAMHD1, NCAM1, CD4, LTBR]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[LIF, E2F7]
GO:0060708;spongiotrophoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;8.390779266560578;0.0014155633914202197;0.7193458537639684;[LIF]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, INPP5D, TLR4, LTF]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, TNF, IL1B, AKT1, FYN, PF4]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, MYB, LTA]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, FYN, CSK, LYN, SYK, BMX, PTK2, FGR, ZAP70, HCK, LCK, BTK]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, LY96, CARD9, NFKB1, NFKBIA]
GO:0046888;negative regulation of hormone secretion;8.0;0.6393367784920305;0.6946683892460153;8.673012807464685;252.0215160505561;5.666199763507158;0.00843493333757307;0.6647697194109919;[GHSR, LIF, INHBA, IL1B]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, MIF, BCL6, BTK]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, PROS1, SIRPG, CXCL13, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, CXCL10, CXCL11, IL6, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, OLR1, FFAR2, CCR7, CCR6, CCR5, CD34, CCR2, ANXA1, FCER1G, SYK, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0001937;negative regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.36028873802138;6.193554689224359;0.002923870244906099;0.6676580400938822;[MEF2C, CAV2, CAV1, PRL, TNF, THBS1, CCL2]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[ABCA1, NR1H2, ITGB3, TNF, NFKBIA, IL6]
GO:0051798;positive regulation of hair follicle development;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;137.70877785042182;7.292166977892469;0.004608988864799761;0.6960420709600095;[TGFB2, TNF]
GO:0038116;chemokine (C-C motif) ligand 21 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038115;chemokine (C-C motif) ligand 19 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, FGR, RAC2, IL13RA2]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[TNF, RACGAP1, NCKAP1L, TLN1, LLGL2]
GO:0048566;embryonic digestive tract development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;33.609109414970646;7.004484905440688;0.001124866645884346;0.6484506956670166;[TGFB2, TNF]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, IL1B, ADAM9, TNFRSF1B, TNF]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, E2F7]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, CCL20, AZU1, SELE, LAT]
GO:0032800;receptor biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.318369324188282;73.9644013438808;8.16763571524637;0.002475521949340158;0.7408135829017477;[TNF]
GO:0072307;regulation of metanephric nephron tubule epithelial cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;122.78518948428719;7.8311634786251565;0.004109509792542791;0.7754860644832351;[YAP1, LIF, PAX2]
GO:0050995;negative regulation of lipid catabolic process;7.0;0.7671156992804218;0.7344772148974115;9.0689084645567;114.83297947662612;6.686031174322154;0.003843356480110741;0.692843310444282;[CNR1, IL1B, AKT1, TNF]
GO:0060431;primary lung bud formation;8.0;1.0;0.875;9.628524252492122;121.16230854056519;9.083926447120524;0.0040551934278544415;0.839552420951524;[HHEX]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, BLNK, TPD52, CR2, IFNA14, IFNA16, NFAM1, ATP11C, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:1901671;positive regulation of superoxide dismutase activity;9.0;1.0;0.896240625180289;9.628524252492122;578.3848868100486;8.67846133901236;0.019358021648928737;0.8400575416471059;[TNF]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[CCL21, KIT, CCR7]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0060559;positive regulation of calcidiol 1-monooxygenase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1344.9571378328073;8.67846133901236;0.04501450502042472;0.8590579283277371;[IFNG, IL1B, TNF]
GO:1901676;positive regulation of histone H3-K27 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;9.777073627680469;0.049809132146875434;0.9481203125901445;[LIF]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, HHEX, TIMP1, ANXA1, ARG1, GLP2R, SIRT1, TGFBR3, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CDKN1A, MYOCD, CDKN2C, TNFAIP3, HHEX, MEN1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, TNFRSF11A, TNFRSF17, TNFSF14, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, LTBR]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, MIF, PRKAR1B, FPR1, TGFA, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, EGR1, ACE, FZD5, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CCR7, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CCL21, CD40LG, PKN1, CCNT2, TNF, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, CALCA, C5AR1, TNFRSF11A, ADRB2, STAP1, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, THBS1, CCL5, FYN, CSK, EGF, MAPK14, CD4]
GO:0035509;negative regulation of myosin-light-chain-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1252.1557676251311;8.16763571524637;0.04190852667538468;0.8501222226412654;[NCKAP1L, TNF]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CCL21, SLC11A1, CCR7, CCL19]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[LRRK2, TNFAIP3, HHEX, RUVBL1, SOX4, AXIN2, SFRP4, SFRP2, DAAM2, NAIP, TLR2, YAP1, JUP, EGF, CAV1, NFKB1, SULF2, COL1A1, BMP2, LGR4]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0030851;granulocyte differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;47.07409398820286;7.069023426578259;0.0015755275618510598;0.6846304993685643;[SPI1, CEBPE, CBFA2T3]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, PYCARD, STAP1, CCL2, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, FLNA, TSPAN5, JUP, RAMP1]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, NTF3, CCR7, EVI5, CCL21, RHOG, TBC1D9, TBCK, EPHA2]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, PDGFRA, CHUK, ARG1, COL4A1, NAIP, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB2, BMP2, TGFB1, KLF5, SPI1, PRL, FOS]
GO:0097022;lymphocyte migration into lymph node;8.0;1.0;0.875;9.628524252492122;30.235634434558513;9.777073627680469;0.001011959474220325;0.875;[CCR7]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[ABCB4, TNF, PDGFD, PDGFC, FYN, PDGFRA, COL1A1, COL4A1]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[JUN, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[PRTN3, CCR7, CCL19]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, TNF, LGALS3, DUSP10, CTLA4, IL13RA2, CCR2, HAVCR2, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, MMP12, ADCYAP1, CEACAM1, XCL1, CLEC12B, INPP5D, LYN, TGFB2, TGFB1, NR1H2, LILRB1, PTPRC, BCL6, PTPN6, FCGR2B]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[TNF, CCL5, SLPI, LTF]
GO:0060693;regulation of branching involved in salivary gland morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;93.99544391330774;7.697632086000634;0.0031459429173709623;0.7167775754447168;[TNF]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[PDPN, TLR4]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0010693;negative regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.7238800504293;8.67846133901236;0.010566994132243301;0.8590579283277371;[TGFB2, TNF]
GO:0035050;embryonic heart tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;7.004484905440688;0.0011047978665365144;0.6484506956670166;[HHEX]
GO:0045994;positive regulation of translational initiation by iron;10.0;1.0;0.9152410118609203;9.628524252492122;1474.0558344206913;9.083926447120524;0.049335322213937396;0.8797934328124444;[TNF]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, GATA3, NLRP3, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, LILRB1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[TLR4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, DUSP10, TIMP3, CSK, EMILIN1, LYN, DUSP1, LIF, DUSP6, NLRP12, TLR4, ATF3]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, JMY]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071103;DNA conformation change;5.0;0.6729672293956388;0.6267246265587396;8.242229891372231;21.24116723228514;5.058574756385375;7.10922751455178E-4;0.5489367601502517;[SMARCAL1, MCM7, NCAPG2, HMGB2, SMC4, SMC2, HHEX, RUVBL2, RUVBL1, ANXA1, MCM4, MCM6, MCM2, BLM, RAD54B, HMGA1, RPA1, RAD50, RAD51, ACIN1, NCAPD2, NCAPD3]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, TCL1A, AKT1, TNFSF11, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CCR7, HLA-DPA1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, PCOLCE, KMO, KIF16B, CALCA, CSF2RB, CORO1A, NFKB1, BSPRY, ALAD, CHUK, CHI3L1, XCL1, MCM2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, CD4, KLF5, IMPDH2, PTPN6, RBMX]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0045080;positive regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;840.1940438043877;7.697632086000634;0.02812053852058526;0.7686572628545723;[EGR1, IL1B, AZU1, TNF]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[TNF, TNFSF11, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CD40LG, PKN1]
GO:0033141;positive regulation of peptidyl-serine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;940.2079225453168;6.781341354126479;0.03146791303539702;0.7792270645443136;[IFNA5, IFNA4, IFNA7, IFNA14, IFNG, IFNA16, IFNA2, LIF, IFNA8, IFNA21, IFNA10]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0061614;pri-miRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;587.6398479969114;7.57984905034425;0.019667776870928726;0.8200627852632958;[SPI1]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, CCR7]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, LIF, PTGS2, MEN1, CTSB]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, GH1, IL6, IFNG, KIT]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, SORT1, TNFRSF10B]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[INPP5D, HOXA7, LYN, LILRB1, INHBA, LILRB3, CEACAM1, TLR4, LTF]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, AZU1, TLR4, THBS1, CCR2]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, HSPD1, MMP12, TLR8, TLR7, TLR4]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, EGR1, TGFB2, TGFB1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, ALAD, MYOCD, ADSL, KCND2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, TEK]
GO:0002876;positive regulation of chronic inflammatory response to antigenic stimulus;9.0;1.0;0.896240625180289;9.628524252492122;533.6829535102606;9.083926447120524;0.01786188817051291;0.8607930461318132;[LTA, TNF]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, IL12RB1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[CCL21, CCR7, CCR6]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[ORM1, LRRK2, PTPN22, TNF, PYCARD, CLEC5A, FFAR2, CD34, HAVCR2, CHUK, SYK, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, CD274, TWIST1, GATA3, NLRP3, CD58, CCL19, FZD5, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[TWIST1, TNF, PYCARD, FFAR2, IL6R, HAVCR2, EGR1, AZU1, MIF, ADCYAP1, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;9.0;1.0;0.896240625180289;9.628524252492122;486.0421787932986;8.67846133901236;0.016267394314649825;0.8400575416471059;[LYN, LRP2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, IL6, LTA, MYD88, TLR2]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, GPNMB, CD34, HAVCR2, GHSR, LILRB1, IRAK3, BPI, TLR4, GPR18]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, TGFB1, CAV1, LIF, IL6]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[CREBZF, SPI1, SIRT1, EZH2]
GO:0061048;negative regulation of branching involved in lung morphogenesis;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;172.0271407751716;9.777073627680469;0.005757593587369696;0.8509193652572005;[TNF]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[TNF, CHEK1, KNTC1, SOX4, MSH6, MSH2, AURKAIP1, BLM, NACC2, SFN, NAE1, TGFB1, PLK2, CDC6, ZWINT, BCL6, CNOT3, EZH2, CDKN1A, TOPBP1, DUSP1, GAS1, PCNA, GPNMB, CCL2, BUB1, E2F7, WEE1]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[LYN]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA2, TNF, PYCARD, SFN, MLH1, TNFRSF1B, SIRT1, MSH6, MSH2, EPHA2]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, GHSR, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0002885;positive regulation of hypersensitivity;10.0;0.7980440201809971;0.8142630219514189;9.439282252853593;636.6186907884354;8.16763571524637;0.021307054661064313;0.8329342821725234;[FCER1G, BTK, CCR7]
GO:2000525;positive regulation of T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;265.86994678880865;9.083926447120524;0.008898427851603871;0.8607930461318132;[CCR7]
GO:0010944;negative regulation of transcription by competitive promoter binding;11.0;1.0;0.9324289523296623;9.628524252492122;1584.3015218227836;7.57984905034425;0.053025146156608326;0.8200627852632958;[HHEX, DACH1]
GO:2000526;positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation;9.0;1.0;0.896240625180289;9.628524252492122;733.9494972534095;9.777073627680469;0.024564629161408138;0.896240625180289;[CCR7]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCR7, CCL19]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CDH5, IGHG1, GHSR, ADCYAP1, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, CNR1, CCL5, CCL4, MAPK14, CD6, TEK, FCGR2B]
GO:0030098;lymphocyte differentiation;5.0;0.6144040707577935;0.597443047239817;8.242229891372231;42.30537076970773;4.498958968449952;0.001415922687300292;0.5203179827304387;[SPI1, SOX4, TPD52, IFNA14, IFNA16, FLT3LG, ATP11C, RUNX2, CLEC4D, MSH2, CARD11, IFNA10, BLM, GATA3, CD79B, CD79A, NKX2-3, IFNA21, EGR1, TGFB1, BCL11B, FZD5, BMX, PTPRC, BCL6, CD28, ITM2A, GPR18, IFNA5, IFNA4, ITK, IFNA7, IFNA2, CD3G, PTPN22, CD3E, IFNA8, CD3D, HHEX, BLNK, CCR9, CCR6, CR2, ANXA1, FCER1G, NFAM1, RHOH, VAV1, ZAP70, LCK, KIT, DLL1, CD4, CD40LG, DNAJA3, FCGR2B, IL18R1]
GO:2000522;positive regulation of immunological synapse formation;8.0;1.0;0.875;9.628524252492122;159.40900365360346;9.777073627680469;0.005335275893496953;0.875;[CCR7]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCR7, CCL19]
GO:0031622;positive regulation of fever generation;9.0;0.8436909121759173;0.8180860812682478;9.454170865347344;276.00155245721845;7.8311634786251565;0.009237523575472428;0.7967266896635242;[CNR1, IL1B, TNFSF11, TNFRSF11A, PTGS2, TNF]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, P2RY13, TNC, TNF, SLC8A1, CDH1, RUVBL2, ADCYAP1, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, TLR6, TLR4]
GO:1903140;regulation of establishment of endothelial barrier;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;90.35426377509846;7.292166977892469;0.003024075894994471;0.747921758369865;[CDH5, IL1B, S1PR3, TNF]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP1, PAQR3, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[CCL21, PTGER2, TGFBR3, P2RY6, AKT1, CCR7, CCL19, PTGDR]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, CYP1B1, EPHB1, SOX4, MEF2C, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FABP7, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, LTA, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, ADCYAP1, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, CYR61, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, CTHRC1, PRRX1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045820;negative regulation of glycolytic process;12.0;0.8933024483968273;0.8947715367885583;9.593432932680852;4965.344842205602;7.292166977892469;0.1661856233483844;0.8210420709600095;[FBP1, CBFA2T3]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, CEBPE, ABLIM3, E2F5, E2F7, PRRX1, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[LILRB1, TNF]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051023;regulation of immunoglobulin secretion;8.0;0.8933024483968273;0.8216512241984136;9.523163736834295;116.24681071054106;6.943860283624253;0.0038906761391443723;0.7301093378270707;[IL6, CD40LG, TNF]
GO:0071550;death-inducing signaling complex assembly;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;40.42272244673708;7.697632086000634;0.0013529121422039536;0.6838982747154925;[TNF]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, TNF, ALAD, GHSR, ANXA1, DUSP1, ANXA3, ARG1, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, ALPL, SDC1]
GO:0071677;positive regulation of mononuclear cell migration;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;295.2864367703214;6.686031174322154;0.009882971298162901;0.7381645703673706;[CCR1, TGFB1, FPR2, PLA2G7, TNF, LGALS3, CXCL10, CXCL12, CCL5, PDGFD, CCL1, S100A14, CCR2]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0071316;cellular response to nicotine;5.0;1.0;0.7902410118609202;9.628524252492122;116.90797783109151;7.697632086000634;0.003912804807657419;0.6838982747154925;[TNF, NFKB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, PTPN6, MNDA]
GO:2000670;positive regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.63842847306384;8.67846133901236;0.004305412433924055;0.8400575416471059;[LYN]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, PHB2, PROK2, TNFSF11, EPHB1, MIF, EPHA3, EPHA2, FPR1, TGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, ELANE, CCR1, JUN, FZD5, LIF, MARCO, NOX4, CD24, EZH2, NRP1, CCR7, CD36, HAVCR2, MAP4K1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, FMR1, MEF2C, NPY, TGFB2, GABRA5, LIF, SLC4A7, UQCRQ]
GO:1903715;regulation of aerobic respiration;7.0;1.0;0.8509193652572005;9.628524252492122;31.21310751045706;7.8311634786251565;0.0010446746184019939;0.7514054297404357;[CBFA2T3]
GO:0045835;negative regulation of meiotic nuclear division;8.0;0.7248374789738407;0.7374187394869203;9.271849308553389;325.6023743920082;7.212124270218933;0.010897618447788233;0.7438283705770736;[MSH2, LIF, FBXO5, BRCA2]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, NCKAP1L, PKN1]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, NFAM1, STAP1]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, LYN, TGFB1, TRPC1, F2R, CXCL10, CXCL11, XCL1, PTPN6, F2RL3]
GO:0050862;positive regulation of T cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.212124270218933;0.01221922354838398;0.7438283705770736;[TRAT1, LCK, CCR7]
GO:2000547;regulation of dendritic cell dendrite assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;8.67846133901236;0.001732417023575362;0.8188169164668168;[CCL21, CCR7, CCL19]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, TNC, PHB2, PAX2, COL1A1, MYB, HOXA2, EPHA3]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, TRAF1]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, CD80, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, JUN, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[TNF, CYR61]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, HOXC10, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0048711;positive regulation of astrocyte differentiation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;472.09912929902924;7.069023426578259;0.015800732996006494;0.7767511986393403;[BMP2, IL1B, LIF]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[TNF, HK3, AKT1, PGM5, NPY1R, FBP1, ATF3, MAPK14]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0061017;hepatoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;47.57053087451796;9.083926447120524;0.0015921428576718348;0.7547934328124444;[HHEX]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, KIT, GATA3, SOX4]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0002439;chronic inflammatory response to antigenic stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;42.97336350789415;8.390779266560578;0.0014382798030929574;0.7522251544931926;[IL1B, TNF]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[ITGAM, LRRK2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, TLE4, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, GATA3, APCDD1, FZD5, NR4A2, VANGL1, SDC1, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, FRZB, CTHRC1, EGF, TMEM64, LGR4]
GO:0070886;positive regulation of calcineurin-NFAT signaling cascade;10.0;1.0;0.9152410118609203;9.628524252492122;339.2927284230194;7.004484905440688;0.011355822276687466;0.7734506956670166;[TNF]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, EPHA3, LYN, SYT2, CXCL12, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, F2R, FASLG, JPH2, PTPRC, LCK, XCL1, CCR7, CCL19, CCR5]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[FOXO1, DNM2, CCR7, CCL19]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, LCK, S100A8, NLRC4, HSPD1, NLRP3, TNFRSF10B, HSPE1, NLRP12, P2RX1]
GO:0016973;poly(A)+ mRNA export from nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;122.0533615230405;7.004484905440688;0.004085016169282269;0.7734506956670166;[HHEX]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, IFNG, PTGS2, FYN, CCT8, CCT7, CCT5, CCT4, TGFB1, JUP, LIF, MAPK14, CCT6A]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL]
GO:0090025;regulation of monocyte chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.5287080193099;6.641579411751319;0.004602962089604771;0.7358913051622797;[LYN, CCR1, CXCL10, CXCL12, CCL5, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, LY96, NFKBIA, S100A14, TLR4]
GO:0002573;myeloid leukocyte differentiation;5.0;0.7369933605727446;0.6587376921472925;8.741221057491218;45.128183839147766;5.311165509025885;0.0015103997003676221;0.5618542629869587;[SPI1, TFRC, TREM2, TNF, HHEX, TNFSF11, CCR7, MEF2C, FCER1G, MMP9, SIRT1, CBFA2T3, OSCAR, KIT, PRTN3, EPHA2, CEBPE, TNFRSF11A, GATA3, CCL19, NKX2-3, JUN, TGFB1, MAPK14, CAMK4, LTBR]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, IGKC, CCL20, CARD9, CD4]
GO:0048298;positive regulation of isotype switching to IgA isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;8.16763571524637;0.04712120069255247;0.8501222226412654;[TGFB1, MSH2, TNFSF13, MLH1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, LAMP2, SKP2, SFRP2, SIK1, ATF3, SEH1L, ABCB4, FOXO1, GAS2L1, LYN, JUN, EIF2S1, NR4A2, COL1A1, CDKN1A, PLEKHF1, LRRK2, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, FYN, SIPA1]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[SPI1, GATA3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, S1PR3, TGFB1, JAG1, KRT19, BMP2]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[LTA, CTSG, CD36, TNF, ELANE]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0010621;negative regulation of transcription by transcription factor localization;11.0;0.9326813400603323;0.8987696223598284;9.604426700913061;1614.1306916489104;8.67846133901236;0.05402350162617884;0.8762458687964789;[HHEX, ID1]
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;8.390779266560578;0.011871713162238609;0.8253454670833372;[LYN, TNFAIP3, TLR6]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[TNF, PYCARD, CD36, IL6R, FCER1G, F2R, TLR1, ADCYAP1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, HSPD1, CARD9, LILRB2, IL6, MYD88, IL17A]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, COL1A1, NOX4, NRP1, NRP2, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, PDGFRA, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB2, TGFB1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[SPI1, TAF9, ELP4, BRCA2]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[SPI1, PF4]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[YAP1, GJC1, TMEM100, HHEX, MYOCD, TGFB1, CAV1, TIE1, PTK2, TGFBR3, ENG]
GO:1903347;negative regulation of bicellular tight junction assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.40702245958384;8.390779266560578;0.003594816381677759;0.7800242071602487;[TNF]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, CHUK, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0022027;interkinetic nuclear migration;6.0;1.0;0.8231203125901445;9.628524252492122;68.32040627354414;7.9853141584524145;0.0022866225136017795;0.7314896500084853;[HHEX]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F7, PRRX1, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX4, TWIST1, PCBP3, EGR1, BCL11A, ID1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, AKT1, GHSR, SIRT1, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, FRZB, HOXA7, MEF2C, TGFB2, ACE, LIF, RUNX2, PAX2, LIN28A, KIT, HOXB4]
GO:0048861;leukemia inhibitory factor signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;28.111912685638995;8.390779266560578;9.408804185094754E-4;0.7800242071602487;[LIF]
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;8.0;0.7866048967936545;0.7683024483968273;9.394909401310617;268.25740884697916;4.746635706288034;0.008978334058114483;0.6177431707607042;[TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, LYN, TGFB2, FZD5, CCL21, CARD9, BMP2, CD40LG, PKN1, LTBR, FCGR2B]
GO:0070667;negative regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.777073627680469;0.0027998878581822827;0.8509193652572005;[LYN]
GO:0070668;positive regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.5280859103553;9.777073627680469;0.002795609865022748;0.8509193652572005;[LYN]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, TLR4]
GO:2000334;positive regulation of blood microparticle formation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;107.44151918580685;9.083926447120524;0.0035959709560594052;0.7876727335416686;[CD36, TNF]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, CD4, IL6, BPI, TLR4, LTF]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MEF2A, MEF2C, PADI4, ATF3, GATA3, JUN, HACE1, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, NFKB1, CIITA, FASLG, HHEX, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, LOXL2, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, C5AR1, NLRP3, CBX4, NR4A2, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0050706;regulation of interleukin-1 beta secretion;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;155.12756668048587;6.166155715036245;0.005191980051049822;0.7305785018834392;[ORM1, PYCARD, NLRP3, CCR7, CCL19, FZD5, NLRP12, TLR8, TLR4]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[TNF, PYCARD, CLEC5A, GHSR, IL1R2, F2R, MIF, CD274, TWIST1, GATA3, NLRP3, LYN, FZD5, ORM1, LRRK2, IFNA2, PTPN22, FFAR2, CCR7, CD34, HAVCR2, ANXA1, CHUK, SYK, IL17RB, MMP12, TLR1, FGR, BANK1, IL1B, IGHD, TLR8, TLR10, TLR6, TLR5, TLR4, TLR2, CD58, CCL19, LILRB1, MAPK14, CD2, NLRP12, FCGR2B, LGR4, CD244, IL17A]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SLC8A1, CTGF, SOX4, MEN1, RMI1, PAX2, IL1B, CALCRL, PTGS2, THBS1, MAP2K6, LYN, EGR1, EIF2B3, TGFB1, LIN28A, NOX4]
GO:0090241;negative regulation of histone H4 acetylation;12.0;0.9326813400603323;0.9144609826203107;9.60254876608886;1490.3225296813393;8.16763571524637;0.049879753865236;0.8658135829017477;[SPI1, SIRT1]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, GATA3, TNF, FOXO1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0046325;negative regulation of glucose import;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.7654042001006;7.138016298065211;0.0028370217946663582;0.7400384854347593;[PID1, TNF]
GO:0042089;cytokine biosynthetic process;6.0;0.6324783794010864;0.6393595022906877;8.181605269555796;87.71441628493068;7.069023426578259;0.0029357225752070525;0.6846304993685643;[CEBPE, CD28, PAWR]
GO:0044027;hypermethylation of CpG island;9.0;1.0;0.896240625180289;9.628524252492122;74.95921705947427;9.083926447120524;0.002508817536065054;0.8607930461318132;[SPI1]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, MAPK14, TNF, OSCAR, TNFSF11, EPHA2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, TLR4, TLR2]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CCL21, CARD9, CD40LG, PKN1, LTBR, FCGR2B]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, ATF3, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, LCK, NLRC4, CCL5, CCL2, P2RX1, MNDA, PPP2R1A, SOX4, SFRP4, SFRP2, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, CTSZ, CTSH, VAV1, IL1B, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, PDGFRB, NLRP3, TGFB2, TGFB1, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, MMP9, DNM2, IFNG, LTA, BCL2A1, THBS1, HSPD1, CNR1, HSPE1, LTBR]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, NCF4, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, ELANE, MARCO]
GO:0034116;positive regulation of heterotypic cell-cell adhesion;6.0;1.0;0.8231203125901445;9.628524252492122;52.08961109106789;7.212124270218933;0.001743392405611612;0.6919486831672181;[CEACAM6, IL1B, TNF]
GO:2000343;positive regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.02652997090885;7.8311634786251565;0.0029796378394510905;0.7514054297404357;[MIF, TNF]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, NLRC4, CD36, TLR6, TLR4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, HSPD1, PYCARD, CD40LG, CD28, XCL1, TLR4, CD34, TLR2]
